Pantoprazol Zentiva (Pantoprazole Sodium Sesquihydrate)

Pantoprazole sodium sesquihydrate, the active ingredient in Pantoprazol Zentiva, is a proton pump inhibitor presented as a solid oral dosage form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoprazol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Zentiva is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing and reduces symptom recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Peptic ulcer disease prevention: lowers ulcer risk when used with NSAIDs or other ulcer‑causing agents. - Helicobacter pylori eradication regimens: serves as a component of triple‑therapy protocols to improve eradication rates.

Pantoprazol Zentiva is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Severe hypersensitivity: rash, angioedema, anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or cardiac arrhythmia. - Vitamin B12 deficiency: possible with prolonged therapy.

Before initiating Pantoprazol Zentiva, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring gastric acidity. - Monitor long‑term users: watch for bone fracture risk and nutrient deficiencies. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Zentiva may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption; avoid concurrent use. - Atazanavir: markedly decreased antiviral exposure; contraindicated.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: slight increase in serum levels; observe for toxicity signs. - Methotrexate (high dose): reduced clearance; check renal function and drug levels. - Clopidogrel: diminished antiplatelet effect; consider alternative therapy. - Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.